scholarly journals Clinical and microbiological characteristics of men with nonobstructive acute pyelonephritis

Medicine ◽  
2021 ◽  
Vol 100 (40) ◽  
pp. e27386
Author(s):  
Min Gu Park ◽  
Sung Yong Cho ◽  
Se Yun Kwon ◽  
Hoon Choi ◽  
Jeong Woo Lee
Author(s):  
Shabnam Tehrani ◽  
Fereshteh Elyasi ◽  
Sara Abolghasemi

Introduction: Acute pyelonephritis is among the most common bacterial infections. Options for initial treatment of pyelonephritis include an extended-spectrum cephalosporin or a fluoroquinolone. In this study, we aimed to compare the clinical outcomes of patients receiving ceftriaxone to those who received levofloxacin for the treatment of acute pyelone-phritis. Methods: In this randomized, open-label trial, hospitalized adults with acute pyelonephritis were treated with ceftriaxone (1g IV every 12 hours) or levofloxacin (750 mg IV daily) for at least 7 days. Clinical and microbiological characteristics were compared among patients treated with ceftriaxone and levofloxacin. Results: A total of 59 patients were randomized, 30 to the ceftriaxone group and 29 to the levofloxacin group. The clinical response for 68.0% of patients in the ceftriaxone group and 56.0% of patients in the levofloxacin group were cured. The mi-crobiological response (pathogen eradication rates) was 68.7% in the ceftriaxone group and 21.4% in the levofloxacin group.(P value=0.00028) Escherichia coliwas the most common pathogen (n = 31), followed by Klebsiella pneumoniae(n = 21). High resistance rates were detected for cotrimoxazole (55%), ciprofloxacin (48%), and ceftriaxone (34.4%) in isolat-ed E.coli. Likewise, all K. pneumoniaeisolates were resistant to ciprofloxacin. Conclusions: Our study indicates that ceftriaxone was more effective than levofloxacin in the treatment of acute pyelone-phritis, on the basis of microbiological response, but there were no statistically significant differences between the treatment groups in the rates of clinical cure.The resistance of uropathogens to the most used antibiotics was relatively high. Choosing the treatment regimen based on susceptibility testing results and shortening the duration of the therapy are now recommend-ed to be the most important approaches to decrease the spread of antibiotic resistance worldwide.


2019 ◽  
Vol 18 (1) ◽  
pp. e542
Author(s):  
J.W. Lee ◽  
M.G. Park ◽  
S.Y. Kwon ◽  
H. Choi ◽  
S.Y. Cho

1993 ◽  
Vol 25 (1) ◽  
pp. 141-143 ◽  
Author(s):  
Mirek Hebelka ◽  
Knut Lincoln ◽  
Torsten Sandberg
Keyword(s):  

2020 ◽  
Vol 16 ◽  
Author(s):  
Marcus Vinicius Martins Rubatino ◽  
Ana Laura Araújo Santos ◽  
Rayssa Araújo dos Santos ◽  
Magali Benjamim de Araújo

: Roxithromycin is one of the most frequently used macrolide antibiotics, a safe group of antimicrobials that acts against Gram-positive bacteria and some Gram-negative bacteria. It is sold in several countries in different dosage forms (tablets and capsules) and strengths (50, 100, 150 and 300 mg). Several analytical methods have been described to quantify roxithromycin in different matrices, such as biological and environmental samples and food. Identifying the main characteristics of the drugs and selecting appropriate analytical methods for their quantification are of paramount importance for understanding the behavior of drugs, metabolites and impurities. This review presents the physicalchemical and microbiological characteristics, properties as well as methods for quantification of roxithromycin in biological fluids, pharmaceutical preparations, food and environmental samples. HPLC coupled to various detection systems is the most used analytical technique to determine roxithromycin in these matrices. Although many analytical methods have been reported for the analysis of this drug, it is very important to include in this context a prospective view, in order to implement new analytical technologies for the quality control of this antimicrobial that contribute to the preservation of economic and environmental impacts.


Sign in / Sign up

Export Citation Format

Share Document